Following sisters of SLE patients may shed light on risk factors and progression of the disease
Search results for: vitamin D
Updated Guidelines and New Therapies for Osteoporosis Coming this Year
Updated guidelines, online assessment tool, and new therapies coming this year
Drug Updates: Information on New Approvals and Medication Safety
Information on New Approvals and Medication Safety
Drug Updates
Information on News Approvals and Medication Safety
Psoriatic Arthritis: From Leeds to the Limelight
Advances in understanding of the disease begin in the 1960s
Annual Meeting Opportunities for Pediatric Rheumatologists
The ACR/ARHP Annual Scientific Meeting is the premier event for specialists in the field of rheumatology, and this year’s planning committee is committed to providing attendees with educational opportunities specifically tailored to their areas of interest.
Quality Advice from Specialty Societies
The ACR’s Quality Stakeholders’ Summit explored quality initiatives from several medical societies
Reading Rheum
Handpicked Reviews of Contemporary Literature
Healthy Bones in Children
Recent research provides insight into this important area of public health
Glucocorticoid-Induced Osteoporosis
Osteoporosis is a condition of weak bone caused by a loss of bone mass and a change in bone structure. Glucocorticoid-induced osteoporosis is a form of osteoporosis caused by taking glucocorticoid medications, such as prednisone (Deltasone, Orasone, etc.), prednisolone (Prelone), dexamethasone (Decadron, Hexadrol), and cortisone (Cortone Acetate). These medications are used to help control many rheumatic diseases, including RA, systemic lupus erythematosus, and polymyalgia rheumatica.
- « Previous Page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- …
- 22
- Next Page »